NRSN Share Price Performance
US$1.26
0.56 (80.88%)
Price US$1.26
Share PriceUS$1.26
NRSN Community Narratives
There are no narratives available yet.
Recent NRSN News & Updates
No updates
NeuroSense Therapeutics Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.36
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
NeuroSense Therapeutics Ltd. Competitors
About NRSN
- Founded
- 2017
- Employees
- 17
- CEO
- WebsiteView website
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. The company’s lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer’s, as well as under preclinical studies for the treatment of Parkinson’s disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer’s disease. The company was incorporated in 2017 and is headquartered in Herzliya, Israel.
Israeli Market Performance
- 7 Days: -1.7%
- 3 Months: 18.6%
- 1 Year: 67.6%
- Year to Date: 27.4%
Over the last 7 days, the market has dropped 1.7%, driven by declines in the Financials and Real Estate sectors of 1.8% and 2.9%, respectively. In contrast to the last week, the market is actually up 68% over the past year. Earnings are forecast to grow by 16% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading